To evaluate possible influences of dietary intervention on the composition of very low-density lipoproteins (VLDL), ten subjects with Type 2 (non-insulin dependent) diabetes mellitus received a hypocaloric regimen. Fifteen healthy subjects served as controls. Ultracentrifuged VLDL were analysed as cholesterol, triglycerides, apolipoprotein B (apo B), and the soluble apolipoproteins C and E (polyacrylam• gel electrophoresis in urea and densitometry) before the study, after 2 weeks and then after 3 months. Compared with the control subjects, the content of cholesterol and apo E in the VLDL was elevated in the diabetic subjects, while the area ratio ofapo C-II to apo C-III1 was lowered. After diet the reduction in VLDL was accompanied by compositional changes: a decrease of the cholesterol/triglyceride ratio and of the apo E/apo C area ratio. The apo C-II/apo C-III, area ratio remained unaffected. We conclude that one beneficial effect of therapeutic intervention in diabetes may lie in lowering the level of possibly atherogenic VLDL-components.
Abnormalities in serum lipoproteins are frequent and may contribute to the increased incidence of atherosclerosis in diabetic patients [1] . Most commonly, triglyceride-rich lipoproteins are elevated [2, 3] . Therapeutic regimens improve hyperglycaemia as well as hypertriglyceridaemia [4] . In very low-density lipoproteins (VLDL), the main density class of triglyceride-rich lipoproteins, apolipoprotein B (apo B) represents the particle concentration [5] , the C-apolipoproteins modulate the degradation of lipoproteins [6] , and apo E is involved in their receptor binding [7] . Only a few data exist on these apolipoproteins in diabetes mellitus [8, 9] , and the effects of diet have not been investigated. We report the influence of a 3-month dietary regimen on VLDL-components in patients with Type 2 (non-insulin dependent) diabetes mellitus.
Patients and Methods
We studied ten diabetic patients (27.6 • 4.1% above the ideal weight (mean • SD) derived from Metropolitan Life Assurances tables, mean age 41 • 16 years, three males, seven females, mean duration of diabetes 1.1 _+ 1.6 years). None of the patients had taken drugs known to affect carbohydrate or lipid metabolism (e.g. hormonal therapy, beta blockers, or diuretic drugs). Baseline recorded values for body weight, 10.00 h blood glucose (10.49 • 2.28 retool/l), daily urinary excretion of glucose (2.4 _+ 2.9 g/day), serum cholesterol (6.00 _+ 0.59 mmol/1), and serum triglycerides (2.61 • 0.71 mmol/l) were taken over a 2-week.period in the outpatient clinic.
The subjects were then hospitalized for-2 weeks. After dietary advice by an experienced dietitian, care of the subjects was undertaken in the outpatient clinic for a further 10 weeks. Dietary treatment consisted of 1 000 calories daily during the first 2 weeks, then 1500 calories daily for the rest of the study. Thirty percent of energy was derived from protein (vegetable protein 10%), 30% from fat, and 40% from carbohydrates. The ratio between polyunsaturated and saturated fatty acids in the diet was 0.8 and the average cholesterol content 0.15 g/day and 1000 calories. The intake of simple carbohydrates was rigidly restricted. The patients kept their physical activity at a constant level.
Body weight, blood glucose (estimations at 10,00 and I3.00 h, hexokinase method, Boehringer kit, Mannheim, FRG), and urinary glucose were measured daily during the first 2 weeks, then weekly. Serum lipids and VLDL were determined after a 12-h fast at the beginning, after 2 weeks, and then after 3 months. Fifteen healthy subjects (same sex distribution, same age range, 6.5 • 2.7% above the ideal weight) on a 3-month isocaloric diet (same food composition as in patients) served as controls.
VLDL were separated from other lipoproteins by tube slicing alter uhracentrifugation in a Beckman rotor 40.3 (d = 1.006 g/mi, 24 h, I05,000 x g at 4~ Cholesterol and triglyceride levels in serum and VLDL were measured enzymatically (Boehringer kits, Mannheim, FRG), VLDL-apo B by electroimmunoassay (inter-assay coefficient of variation 2.l%) [10] . Equal volumes of VLDL and tetramethylurea were then mixed and centrifuged. Aher determination of the protein content in the supernatant [11] , 0.1 mg of soluble VLDL-apolipoproreins were applied to polyacrylamide gel columns (7.5%), containing 8 tool/1 ~Jrea, and electrophoresis was carried out [t2]. The resulting 
Results
Compared with the control subjects, the diabetic patients had elevated concentrations of serum lipids and VLDL. With regard to the VLDL-composition, they had an elevated cholesterol/triglyceride ratio and an elevated apo E/apo C area ratio, but a lowered apo C-II/apo C-III1 area ratio (Tables 1 and 2 ). The dietary treatment resulted in a reduction of serum lipid and VLDL-levels and the cholesterol/triglyceride ratio in VLDL. Furthermore, there was a decrease of the apo E content resulting in a fall of the apo E/apo C area ratio after diet. These changes were maintained after the initial period in hospital, i. e. the 3-month values were not significantly different from the 2-week values. The diet did not influence the distribution of the C-apolipoproteins. The apo C-II/apo C-III1 area, ratio remained lowered in the diabetic patients. Sex differences in the response of the VLDL-changes to diet were not observed. The decrease of mean body weight was 4.2 + 2.9 kg after 2 weeks and 10,8 _+ 2.9 kg after 3 months (12.9 + 5.1% above the ideal weight at the end of the study). The decrease of blood glucose concentrations by diet (Table 1 ) resulted in a disappearance of glycosuria.
Discussion
In agreement with the findings of Gabor et al. [9] , we found a lowered apo C-II/apo C-III1 area ratio in diabetic patients compared with control subjects. Furthermore, our slightly, obese and hypertriglyceridaemic diabetic patients had an elevated cholesterol and apo E content in VLDL which are assumed to reflect an elevated concentration of remnant particles [5] .
Together with the reported increase of intermediatedensity lipoproteins [13] this accumulation of remnant lipoproteins in diabetic patients implies that there are alterations in the catabolic pathway of triglyceride-rich lipoproteins. One explanation may be the altered distribution of apo C in VLDL [9] , finally favouring a re-duced activity of lipoprotein lipase in uncontrolled diabetes [14] . Another possibility is an altered turnover rate of apo B in diabetes mellitus [8] . Thirdly, changes in high-density lipoproteins (HDL) with a decrease of the HDL2-subfraction in Type 2 diabetes may be responsible for disturbances in the catabolism of triglyceriderich lipoproteins [13, 15, 16] . Comparable alterations of the HDL-subfractions have been reported in obese subjects without diabetes [17] .
As demonstrated in our study, a hypocaloric diet not only reduces VLDL-concentrations, but also changes their composition. It cannot be clearly distinguished, whether the improved diabetic control, the improved hypertriglyceridaemia, or the weight loss is the prime factor in influencing the VLDL-components. Nevertheless, the fall of the cholesterol and apo E content in VLDL points at a preferential elimination of remnant particles. Similar changes of the VLDL-composition have been described after a diet poor in cholesterol and high in polyunsaturated fatty acids in normal men [18] and after hormonal substitution in hypothyroid patients [19] . It remains to be established which mechanisms other than the apo E isoprotein distribution (disturbed in Type III hyperlipoproteinaemia) are responsible for the remnant catabolism. There is some evidence that remnants are easily taken up by tissue cells, causing cholesterol accumulation [20, 21] and may be associated with an increased risk of atherosclerosis [22] . One beneficial effect of diet in diabetes may, therefore, lie in lowering the level of possibly atherogenic VLDL.
